Trials / Active Not Recruiting
Active Not RecruitingNCT05298904
Pro-active Genetic Testing in Kidney Transplant Patients
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 177 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the prevalence of genetic mutations that increase the risk of cancer and other medically actionable diseases in kidney transplant patients and to assess the impact of genetic testing on subsequent surveillance for cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Genetic Health Screen Panel | This panel covers cardiomyopathy genes, and cancer genes. The results of this panel are reported as Positive (pathogenic or likely pathogenic mutation identified in one or more genes) or Negative (no pathogenic/likely pathogenic mutations identified). |
Timeline
- Start date
- 2022-03-28
- Primary completion
- 2037-03-01
- Completion
- 2038-03-01
- First posted
- 2022-03-28
- Last updated
- 2026-01-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05298904. Inclusion in this directory is not an endorsement.